Genome & Company (KOSDAQ:314130)

Genome & Company Statistics

Total Valuation

KOSDAQ:314130 has a market cap or net worth of KRW 81.29 billion. The enterprise value is 87.28 billion.

Market Cap	81.29B
Enterprise Value	87.28B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:314130 has 31.09 million shares outstanding. The number of shares has increased by 7.23% in one year.

Current Share Class	31.09M
Shares Outstanding	31.09M
Shares Change (YoY)	+7.23%
Shares Change (QoQ)	-53.75%
Owned by Insiders (%)	20.83%
Owned by Institutions (%)	13.56%
Float	19.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.72
PB Ratio	0.88
P/TBV Ratio	4.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.58
EV / Sales	2.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.18

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.35.

Current Ratio	2.85
Quick Ratio	2.60
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	-2.30
Interest Coverage	-5.46

Financial Efficiency

Return on equity (ROE) is -24.98% and return on invested capital (ROIC) is -10.31%.

Return on Equity (ROE)	-24.98%
Return on Assets (ROA)	-9.01%
Return on Invested Capital (ROIC)	-10.31%
Return on Capital Employed (ROCE)	-19.48%
Revenue Per Employee	304.46M
Profits Per Employee	-194.34M
Employee Count	98
Asset Turnover	0.20
Inventory Turnover	2.27

Taxes

Income Tax	-957.07M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.06% in the last 52 weeks. The beta is 1.13, so KOSDAQ:314130's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-41.06%
50-Day Moving Average	2,840.80
200-Day Moving Average	2,850.60
Relative Strength Index (RSI)	39.44
Average Volume (20 Days)	179,601

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:314130 had revenue of KRW 29.84 billion and -19.04 billion in losses. Loss per share was -619.34.

Revenue	29.84B
Gross Profit	18.16B
Operating Income	-21.57B
Pretax Income	-26.22B
Net Income	-19.04B
EBITDA	-14.09B
EBIT	-21.57B
Loss Per Share	-619.34

Balance Sheet

The company has 78.02 billion in cash and 32.53 billion in debt, giving a net cash position of 45.49 billion or 1,463.34 per share.

Cash & Cash Equivalents	78.02B
Total Debt	32.53B
Net Cash	45.49B
Net Cash Per Share	1,463.34
Equity (Book Value)	92.62B
Book Value Per Share	1,323.70
Working Capital	56.86B

Cash Flow

In the last 12 months, operating cash flow was -12.02 billion and capital expenditures -2.11 billion, giving a free cash flow of -14.13 billion.

Operating Cash Flow	-12.02B
Capital Expenditures	-2.11B
Free Cash Flow	-14.13B
FCF Per Share	-454.57

Margins

Gross margin is 60.85%, with operating and profit margins of -72.31% and -63.83%.

Gross Margin	60.85%
Operating Margin	-72.31%
Pretax Margin	-87.87%
Profit Margin	-63.83%
EBITDA Margin	-47.24%
EBIT Margin	-72.31%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:314130 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.23%
Shareholder Yield	n/a
Earnings Yield	-23.43%
FCF Yield	-17.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 6, 2024
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:314130 has an Altman Z-Score of -1.53 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.53
Piotroski F-Score	4